SS-31 (Elamipretide) in 2025: The FDA-Approved Mitochondrial Reset for Long COVID and ME/CFS

Description: Welcome back to The Human 5.0 Project! In this episode, we dive into SS-31 (Elamipretide) — the peptide that became the first FDA-approved mitochondrial repair therapy for a rare disease in 2025, and how it’s transforming our understanding of fatigue medicine.

In this episode, we cover:

• Why SS-31 exploded in 2025 and the human data behind it

• How SS-31 works inside mitochondria to restore energy production and reduce post-viral crashes

• The exact labs that show it’s working and the research-grade protocols used in trials

• What the FDA approval for Barth syndrome means and why SS-31 is still off-label for Long COVID and ME/CFS

If you’re struggling with relentless fatigue or know someone who is, this episode is for you.

📥 Download the free SS-31 Protocol Guide (labs, stacks, dosing frameworks):

🔔 Subscribe for more cutting-edge biohacking insights.

For more longevity insights and protocols, check out biohackerdepot.com – your go-to resource for cutting-edge health optimization strategies.

And if you're sourcing research peptides , peptidesphere.com has a curated selection of peptides and bioregulators with detailed info on quality and applications.

#SS31 #Elamipretide #MitochondrialHealth #LongCOVID #ME/CFS #FatigueRecovery #FDAApproved #Mitochondria #Biohacking #FunctionalMedicine #ChronicFatigue #HealthTech #Human5.0Project #MitochondrialRepair #EnergyReset#Human50Project